Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 296 | $225,190,504 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
22 Feb 2023 16:25 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 21 Feb 2023 | Sale | 1,843 | 294.03 | 541,897 | D |
01 May 2023 16:26 | VRTX | VERTEX PHARMACEUTICALS INC | KEWALRAMANI RESHMA | CEO & President | 27 Apr 2023 | Sale | 1,611 | 338.69 | 545,630 | D |
01 May 2023 16:26 | VRTX | VERTEX PHARMACEUTICALS INC | KEWALRAMANI RESHMA | CEO & President | 27 Apr 2023 | Sale | 1,668 | 339.43 | 566,169 | D |
16 Feb 2023 16:11 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 14 Feb 2023 | Sale | 1,888 | 300.11 | 566,608 | D |
14 Feb 2023 16:49 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 13 Feb 2023 | Sale | 1,893 | 299.36 | 566,688 | D |
16 Feb 2023 16:16 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 14 Feb 2023 | Sale | 1,902 | 300.29 | 571,152 | D |
13 Feb 2024 16:48 | VRTX | VERTEX PHARMACEUTICALS INC | AMBROSE KRISTEN | SVP & Chief Accounting Officer | 12 Feb 2024 | Sale | 1,374 | 420.24 | 577,410 | D |
16 Feb 2023 16:14 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 14 Feb 2023 | Sale | 2,003 | 299.13 | 599,157 | D |
18 Jul 2023 16:17 | VRTX | VERTEX PHARMACEUTICALS INC | SACHS BRUCE I | Director | 17 Jul 2023 | Sale | 1,697 | 355.54 | 603,351 | D |
14 Feb 2023 16:53 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 13 Feb 2023 | Sale | 2,028 | 298.42 | 605,196 | D |
04 May 2023 16:50 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 03 May 2023 | Sale | 1,800 | 350.53 | 630,954 | D |
14 Feb 2023 16:49 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 13 Feb 2023 | Sale | 2,160 | 298.47 | 644,695 | D |
16 Feb 2023 16:11 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 14 Feb 2023 | Sale | 2,165 | 299.08 | 647,508 | D |
25 Jan 2023 16:08 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 23 Jan 2023 | Sale | 2,129 | 312.02 | 664,291 | D |
04 May 2023 16:50 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 03 May 2023 | Sale | 2,008 | 349.22 | 701,234 | D |
17 Aug 2022 17:39 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 15 Aug 2022 | Sale | 2,339 | 303.78 | 710,541 | D |
29 May 2024 16:08 | VRTX | VERTEX PHARMACEUTICALS INC | KEWALRAMANI RESHMA | CEO & President | 24 May 2024 | Sale | 1,565 | 457 | 715,205 | D |
04 May 2023 16:51 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 03 May 2023 | Sale | 2,053 | 350.44 | 719,453 | D |
13 Feb 2024 16:56 | VRTX | VERTEX PHARMACEUTICALS INC | BILLER JONATHAN | EVP and Chief Legal Officer | 12 Feb 2024 | Sale | 1,738 | 418.77 | 727,822 | D |
20 Mar 2023 16:26 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 16 Mar 2023 | Sale | 2,482 | 300.54 | 745,940 | D |
25 Jan 2023 16:08 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 24 Jan 2023 | Sale | 2,511 | 312.29 | 784,160 | D |
27 Jan 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 25 Jan 2023 | Sale | 2,621 | 314.1 | 823,256 | D |
14 Feb 2024 16:04 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 12 Feb 2024 | Sale | 2,009 | 419.22 | 842,213 | D |
14 Apr 2023 16:19 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 12 Apr 2023 | Sale | 2,625 | 327.43 | 859,504 | D |
25 Aug 2023 16:14 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 23 Aug 2023 | Sale | 2,500 | 355 | 887,500 | D |
14 Apr 2023 16:14 | VRTX | VERTEX PHARMACEUTICALS INC | SACHS BRUCE I | Director | 12 Apr 2023 | Sale | 2,917 | 325.65 | 949,921 | D |
09 May 2023 16:15 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 08 May 2023 | Sale | 2,850 | 350 | 997,500 | D |
05 Jun 2024 16:08 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 03 Jun 2024 | Sale | 2,175 | 460 | 1,000,500 | D |
03 Jun 2024 16:09 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 31 May 2024 | Sale | 2,250 | 445 | 1,001,250 | D |
31 May 2024 16:19 | VRTX | VERTEX PHARMACEUTICALS INC | BOZIC CARMEN | EVP and CMO | 29 May 2024 | Sale | 2,280 | 445.56 | 1,015,877 | D |
03 Jun 2024 16:09 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 30 May 2024 | Sale | 2,350 | 439.11 | 1,031,908 | D |
28 Feb 2023 16:40 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 27 Feb 2023 | Sale | 3,636 | 287.23 | 1,044,368 | D |
21 Nov 2023 16:07 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 20 Nov 2023 | Sale | 3,000 | 349.88 | 1,049,640 | D |
13 Jun 2024 16:11 | VRTX | VERTEX PHARMACEUTICALS INC | BOZIC CARMEN | EVP and CMO | 12 Jun 2024 | Sale | 2,280 | 478 | 1,089,840 | D |
28 Feb 2023 16:47 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 27 Feb 2023 | Sale | 3,834 | 287.16 | 1,100,971 | D |
04 Jan 2024 16:17 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 02 Jan 2024 | Sale | 3,000 | 405 | 1,215,000 | D |
19 Jan 2023 16:07 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 17 Jan 2023 | Sale | 4,000 | 312.03 | 1,248,120 | D |
23 Feb 2024 16:10 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 21 Feb 2024 | Sale | 3,002 | 421.77 | 1,266,154 | D |
27 Feb 2024 16:59 | VRTX | VERTEX PHARMACEUTICALS INC | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 26 Feb 2024 | Sale | 3,004 | 425.7 | 1,278,803 | D |
17 Aug 2022 17:39 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 15 Aug 2022 | Sale | 4,242 | 301.61 | 1,279,430 | D |
21 Jul 2022 16:48 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 19 Jul 2022 | Sale | 4,561 | 287.83 | 1,312,793 | D |
13 Feb 2024 16:46 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 12 Feb 2024 | Sale | 3,145 | 420.24 | 1,321,655 | D |
14 Apr 2023 16:19 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 12 Apr 2023 | Sale | 4,068 | 326.45 | 1,327,999 | D |
23 Feb 2024 16:20 | VRTX | VERTEX PHARMACEUTICALS INC | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 21 Feb 2024 | Sale | 3,191 | 421.77 | 1,345,868 | D |
13 Feb 2024 17:15 | VRTX | VERTEX PHARMACEUTICALS INC | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 12 Feb 2024 | Sale | 3,222 | 420.24 | 1,354,013 | D |
18 Jul 2023 16:17 | VRTX | VERTEX PHARMACEUTICALS INC | SACHS BRUCE I | Director | 17 Jul 2023 | Sale | 3,842 | 357.29 | 1,372,708 | D |
10 Aug 2022 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 09 Aug 2022 | Sale | 4,790 | 300.53 | 1,439,539 | D |
30 May 2024 16:07 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 28 May 2024 | Sale | 3,250 | 454.79 | 1,478,068 | D |
05 Jun 2024 16:11 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 03 Jun 2024 | Sale | 3,250 | 460 | 1,495,000 | D |
23 Feb 2024 16:12 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 21 Feb 2024 | Sale | 3,603 | 421.77 | 1,519,637 | D |
04 May 2023 16:50 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 02 May 2023 | Sale | 4,645 | 349.48 | 1,623,335 | D |
21 Jul 2022 16:48 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 19 Jul 2022 | Sale | 5,737 | 288.67 | 1,656,100 | D |
21 Feb 2024 16:13 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 20 Feb 2024 | Sale | 4,002 | 420.79 | 1,684,002 | D |
21 Feb 2024 16:38 | VRTX | VERTEX PHARMACEUTICALS INC | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 20 Feb 2024 | Sale | 4,254 | 420.79 | 1,790,041 | D |
27 Feb 2024 16:24 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 26 Feb 2024 | Sale | 4,239 | 425.7 | 1,804,542 | D |
13 Feb 2024 16:51 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 12 Feb 2024 | Sale | 4,295 | 420.24 | 1,804,931 | D |
16 Feb 2024 16:07 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 14 Feb 2024 | Sale | 4,356 | 419.04 | 1,825,338 | D |
21 Jul 2022 16:48 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 19 Jul 2022 | Sale | 6,604 | 289.48 | 1,911,726 | D |
15 Nov 2023 16:16 | VRTX | VERTEX PHARMACEUTICALS INC | KEWALRAMANI RESHMA | CEO & President | 13 Nov 2023 | Sale | 5,097 | 377 | 1,921,569 | D |
05 Oct 2023 16:30 | VRTX | VERTEX PHARMACEUTICALS INC | BOZIC CARMEN | EVP and CMO | 03 Oct 2023 | Sale | 5,651 | 345.28 | 1,951,177 | D |
16 Feb 2024 16:07 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 15 Feb 2024 | Sale | 4,655 | 419.16 | 1,951,190 | D |
21 Sep 2023 16:15 | VRTX | VERTEX PHARMACEUTICALS INC | BOZIC CARMEN | EVP and CMO | 19 Sep 2023 | Sale | 5,651 | 351 | 1,983,501 | D |
14 Aug 2023 16:08 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 10 Aug 2023 | Sale | 5,750 | 345.79 | 1,988,293 | D |
07 Sep 2023 16:29 | VRTX | VERTEX PHARMACEUTICALS INC | BOZIC CARMEN | EVP and CMO | 05 Sep 2023 | Sale | 5,651 | 352.66 | 1,992,882 | D |
02 Nov 2023 16:07 | VRTX | VERTEX PHARMACEUTICALS INC | BOZIC CARMEN | EVP and CMO | 31 Oct 2023 | Sale | 5,651 | 355.92 | 2,011,304 | D |
21 Feb 2024 16:19 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 20 Feb 2024 | Sale | 4,804 | 420.79 | 2,021,475 | D |
15 Dec 2023 16:23 | VRTX | VERTEX PHARMACEUTICALS INC | KEWALRAMANI RESHMA | CEO & President | 13 Dec 2023 | Sale | 5,098 | 397 | 2,023,906 | D |
18 Jul 2023 16:17 | VRTX | VERTEX PHARMACEUTICALS INC | SACHS BRUCE I | Director | 17 Jul 2023 | Sale | 5,711 | 356.75 | 2,037,399 | D |
19 Oct 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | BOZIC CARMEN | EVP and CMO | 17 Oct 2023 | Sale | 5,651 | 373.25 | 2,109,236 | D |
17 Aug 2022 17:39 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 15 Aug 2022 | Sale | 6,948 | 305.38 | 2,121,780 | D |
17 Aug 2022 17:39 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 15 Aug 2022 | Sale | 6,990 | 304.67 | 2,129,643 | D |
27 Feb 2024 16:37 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 26 Feb 2024 | Sale | 5,034 | 425.7 | 2,142,974 | D |
16 Nov 2023 16:15 | VRTX | VERTEX PHARMACEUTICALS INC | BOZIC CARMEN | EVP and CMO | 14 Nov 2023 | Sale | 5,650 | 380.82 | 2,151,633 | D |
14 Apr 2023 16:14 | VRTX | VERTEX PHARMACEUTICALS INC | SACHS BRUCE I | Director | 12 Apr 2023 | Sale | 8,026 | 327.48 | 2,628,354 | D |
18 Jul 2023 16:13 | VRTX | VERTEX PHARMACEUTICALS INC | KEWALRAMANI RESHMA | CEO & President | 17 Jul 2023 | Sale | 7,828 | 355 | 2,778,940 | D |
10 Jan 2024 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 08 Jan 2024 | Sale | 6,648 | 419.07 | 2,785,977 | D |
27 Jul 2022 16:17 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 25 Jul 2022 | Sale | 10,471 | 283.42 | 2,967,691 | D |
20 Jun 2023 16:07 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 15 Jun 2023 | Sale | 8,603 | 349 | 3,002,447 | D |
27 Jan 2023 16:13 | VRTX | VERTEX PHARMACEUTICALS INC | KEWALRAMANI RESHMA | CEO & President | 25 Jan 2023 | Sale | 10,000 | 315.05 | 3,150,500 | D |
24 May 2024 16:13 | VRTX | VERTEX PHARMACEUTICALS INC | SACHS BRUCE I | Director | 22 May 2024 | Sale | 7,073 | 448 | 3,168,704 | D |
14 Apr 2023 16:14 | VRTX | VERTEX PHARMACEUTICALS INC | SACHS BRUCE I | Director | 12 Apr 2023 | Sale | 10,357 | 326.46 | 3,381,146 | D |
28 Jun 2022 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | KEWALRAMANI RESHMA | CEO & President | 24 Jun 2022 | Sale | 11,689 | 291.3 | 3,405,006 | D |
15 Dec 2023 16:20 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 13 Dec 2023 | Sale | 8,603 | 399 | 3,432,597 | D |
13 Jun 2024 16:09 | VRTX | VERTEX PHARMACEUTICALS INC | ATKINSON EDWARD MORROW III | EVP, Chief Technical Ops. Off. | 12 Jun 2024 | Sale | 7,288 | 478 | 3,483,664 | D |
14 Aug 2023 16:09 | VRTX | VERTEX PHARMACEUTICALS INC | KEARNEY TERRENCE C | Director | 10 Aug 2023 | Sale | 10,000 | 350 | 3,500,000 | D |
14 Aug 2023 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | SACHDEV AMIT | EVP, Chief Patient Officer | 10 Aug 2023 | Sale | 10,031 | 350 | 3,510,850 | D |
17 Aug 2022 17:40 | VRTX | VERTEX PHARMACEUTICALS INC | KEWALRAMANI RESHMA | CEO & President | 15 Aug 2022 | Sale | 11,689 | 305.06 | 3,565,846 | D |
27 Jul 2022 16:17 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 25 Jul 2022 | Sale | 13,869 | 279.44 | 3,875,553 | D |
08 Nov 2023 16:11 | VRTX | VERTEX PHARMACEUTICALS INC | SACHS BRUCE I | Director | 06 Nov 2023 | Sale | 11,250 | 385 | 4,331,250 | D |
18 Oct 2023 16:17 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 16 Oct 2023 | Sale | 12,962 | 374 | 4,847,788 | D |
15 Dec 2023 16:33 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 13 Dec 2023 | Sale | 13,254 | 399.41 | 5,293,780 | D |
22 May 2024 16:21 | VRTX | VERTEX PHARMACEUTICALS INC | KEWALRAMANI RESHMA | CEO & President | 20 May 2024 | Sale | 15,202 | 447 | 6,795,294 | D |
19 Dec 2023 16:15 | VRTX | VERTEX PHARMACEUTICALS INC | KEWALRAMANI RESHMA | CEO & President | 15 Dec 2023 | Sale | 17,135 | 407 | 6,973,945 | D |
27 Jul 2022 16:17 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 25 Jul 2022 | Sale | 32,983 | 280.37 | 9,247,444 | D |
27 Jul 2022 16:17 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 25 Jul 2022 | Sale | 34,090 | 281.27 | 9,588,494 | D |
27 Jul 2022 16:17 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 25 Jul 2022 | Sale | 40,666 | 282.43 | 11,485,298 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)